Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 33

Results For "2020"

633 News Found

Proactive For Her raises US $ 5.5 million in Series A Round
Startup | February 16, 2022

Proactive For Her raises US $ 5.5 million in Series A Round

The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru


Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
News | February 14, 2022

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered


Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment
News | February 11, 2022

Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment

Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad


Marksans Pharma Q3FY22 PAT at Rs. 48.27 crore
News | February 11, 2022

Marksans Pharma Q3FY22 PAT at Rs. 48.27 crore

Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021


Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis
Biotech | February 08, 2022

Biogen and Xbrane announce commercialization and license agreement for biosimilar to treat rheumatoid arthritis

Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane


Granules India Q3FY22 PAT at Rs 100.88 cr.
News | February 08, 2022

Granules India Q3FY22 PAT at Rs 100.88 cr.

Granules India has reported consolidated financial results for the period ended December 31, 2021


AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
News | February 08, 2022

AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.

Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021


Suven Pharma Q3FY22 PAT at Rs. 160.06 crore
News | February 08, 2022

Suven Pharma Q3FY22 PAT at Rs. 160.06 crore

Suven Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.


Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
News | February 05, 2022

Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore

Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021


Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore
News | February 05, 2022

Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore

Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021